S100A4 and acute myeloid leukemia: By comparing the nuclear proteome and transcriptome of AML progenitor cells with those of normal human CD34 cells, some researchers have found that knockdown of S100A4 affects the survival of AML cell lines, but not normal hematopoietic stem cell progenitors (Alanazi et al., 2020).